Menarini Silicon Biosystems
Ana Aguilar, EMBA, serves as the Chief Financial Officer at Menarini Silicon Biosystems, where leadership encompasses financial, treasury, controlling, IT, and risk management functions since 2018. Prior experience includes roles as Senior Finance Manager at Cerner Corporation, where oversight included post-acquisition integration following the purchase of Siemens Health Services, and as Senior Finance Manager for Siemens Health Services, managing a $1 billion software segment. Ana's extensive background at Siemens AG spans various finance roles, including operational audit management and internal auditing, with a consistent focus on compliance and finance functions. Educational credentials include an Executive Master of Business Administration from Drexel University and dual degrees in Finance and Public Accounting from Universidad Panamericana.
This person is not in any offices
Menarini Silicon Biosystems
1 followers
Menarini Silicon Biosystems offers unique rare cell technologies and solutions that provide clinical researchers with access to unparalleled resolution in the study of cells and their molecular characterization. The company’s CELLSEARCH® and DEPArray™ technologies together provide an end-to-end solution for enumeration and sorting of rare cells with single-cell precision. Menarini Silicon Biosystems, based in Bologna, Italy, and Huntingdon Valley, PA, US, is a wholly-owned subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology, and diagnostics company headquartered in Florence, Italy, with 17,640 employees in 136 countries. Read our Netiquette here: www.siliconbiosystems.com/netiquette